Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 7;18(5):692.
doi: 10.3390/ph18050692.

Nitropyridines in the Synthesis of Bioactive Molecules

Affiliations
Review

Nitropyridines in the Synthesis of Bioactive Molecules

Alexey Starosotnikov et al. Pharmaceuticals (Basel). .

Abstract

Pyridines are one of the most important and promising classes of N-heterocycles actively studied in modern organic and medicinal chemistry; in particular, pyridine is a privileged structural motif in drug design. From a synthetic organic chemistry perspective, nitropyridines can be considered as convenient and readily available precursors for a wide range of mono- and polynuclear heterocyclic systems demonstrating diverse activities, such as antitumor, antiviral, anti-neurodegenerative, etc. This review is an analysis of the literature on the use of nitropyridines for the synthesis of biologically active compounds, covering the period from 2015 to the present.

Keywords: biological activity; coordination compounds; heterocycles; nitro group; nitropyridines; radiolabeled compounds.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Scheme 1
Scheme 1
Synthesis of potent JAK2 inhibitors 4 and 6. Data from [20].
Scheme 2
Scheme 2
Bussiere’s method for the synthesis of GSK3 inhibitors 10 [21].
Scheme 3
Scheme 3
Synthesis of potent kinase p70S6Kβ inhibitor 13. Adopted from [22].
Scheme 4
Scheme 4
A method for the synthesis of 4-aza-6-nitrobenzofuroxan 16 [24].
Scheme 5
Scheme 5
Synthesis of nitropyridine-containing potential urease inhibitors 19. Data from [25].
Scheme 6
Scheme 6
Synthesis of novel urease inhibitors 20. Data from [26].
Scheme 7
Scheme 7
SNH alkylamination of 3-nitroquinoline 22. Data from [33].
Scheme 8
Scheme 8
Synthesis of antibacterial 3-nitropyridines [34].
Scheme 9
Scheme 9
Preparation of epoxybenzooxocino[4,3-b]pyridine derivatives. Data from [35].
Scheme 10
Scheme 10
Synthesis of 3,5-dinitropyrydine containing fluorophores [36,37,38].
Scheme 11
Scheme 11
Synthesis of nitropyridine-based compounds with antimalarial activity. Data from [39].
Scheme 12
Scheme 12
Synthesis of nitropyridine-linked 4-arylidenethiazolidin-4-ones 35. Data from [40].
Scheme 13
Scheme 13
Synthesis of novel imidazo[4,5-b]pyridines [41].
Scheme 14
Scheme 14
Synthesis of nitropyridine-containing herbicides. Data from [42].
Scheme 15
Scheme 15
Synthesis of pyridyloxy-substituted acetophenone oxime ethers 44. Data from [43].
Scheme 16
Scheme 16
Nitropyridine insecticides [44].
Scheme 17
Scheme 17
Synthesis of pyridine-chromene ligand 47 and its metal complexes. Data from [45].
Scheme 18
Scheme 18
Synthesis of pyridine-chromene ligand 47 and its metal complexes [46].
Scheme 19
Scheme 19
Synthesis of copper and zinc complexes 51 with (5-nitropyridin-2-yl)imine ligands. Adopted from [47].
Scheme 20
Scheme 20
Synthesis of the Ru-arene-dinitropyridinylmethylene complex. Data from [48].
Scheme 21
Scheme 21
Preparations of Pt(II) complex of 2-amino-5-nitropyridine 33. Data from [49].
Scheme 22
Scheme 22
Synthesis of novel photoactive Pt(IV) complexes with heterocyclic ligands [50].
Scheme 23
Scheme 23
Nitropyridine complexes with antibacterial and antifungal activities. Data from [53].
Scheme 24
Scheme 24
Synthesis of DNA-PK inhibitor AZD7648. Data from [54].
Scheme 25
Scheme 25
Solid-phase synthesis of PDE4 inhibitors 69. Data from [55].
Scheme 26
Scheme 26
Approach to potential inhibitor of cyclin G-associated kinase [56].
Scheme 27
Scheme 27
Synthesis of semicarbazide-sensitive amine oxidase (SSAO) inhibitors 77. Data from [57].
Scheme 28
Scheme 28
Synthesis of pyridine-based MALT1 inhibitors [59].
Scheme 29
Scheme 29
Synthesis of 10-substituted 3,6-diazaphenothiazines 86 based on nitropyridines. Data from [60].
Scheme 30
Scheme 30
Synthesis of Mannich bases 88 active against prostate cancer cells. Data from [61].
Scheme 31
Scheme 31
Antitumor N-methylpyridinium salts. Data from [63].
Scheme 32
Scheme 32
Synthesis of Shiff bases 92. Data from [64].
Scheme 33
Scheme 33
Synthesis of antimicrobial pyridoxazinone derivatives. Data from [65].
Scheme 34
Scheme 34
Synthesis of antimicrobial (pyridin-2-yl)piperazine derivatives 98. Data from [66].
Scheme 35
Scheme 35
Synthesis of novel acyclic phosphonate nucleotide analogs 101103. Data from [67].
Scheme 36
Scheme 36
Synthesis of imidazo[4,5-b]pyridines 108 from 3,5-dinitropyridines. Data from [68].
Scheme 37
Scheme 37
Synthetic route to PET tau tracer [11C]PBB3. Data from [71].
Scheme 38
Scheme 38
Radiochemical synthesis of [18F]4-amino-3-fluoro-5-methylpyridine. Data from [72].
Scheme 39
Scheme 39
Radiosynthesis of P2X7R imaging agent 18F-JNJ64413739. Data from [74].
Scheme 40
Scheme 40
Synthesis of [18F]fluoropyridine-losartan. Data from [75].
Scheme 41
Scheme 41
The synthesis of [18F]FMN3PU via replacement of the nitro group [76].
Scheme 42
Scheme 42
Synthesis of [18F]T807. Data from [77].

Similar articles

References

    1. Ling Y., Hao Z.-Y., Liang D., Zhang C.-L., Liu Y.-F., Wang Y. The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design. Drug Des. Dev. Ther. 2021;15:4289–4338. doi: 10.2147/DDDT.S329547. - DOI - PMC - PubMed
    1. Starosotnikov A.M., Bastrakov M.A. Recent Developments in the Synthesis of HIV-1 Integrase Strand Transfer Inhibitors Incorporating Pyridine Moiety. Int. J. Mol. Sci. 2023;24:9314. doi: 10.3390/ijms24119314. - DOI - PMC - PubMed
    1. Cole J.M., Goeta A.E., Howard J.A.K., McIntyre G.J. X-ray and neutron diffraction studies of the non-linear optical compounds MBANP and MBADNP at 20 K: Charge-density and hydrogen-bonding analyses. Acta Cryst. 2002;B58:690–700. doi: 10.1107/S0108768102006109. - DOI - PubMed
    1. Baca A.G., Lai W.C. Solution Processable Thin-Film Transistors. 9082983. U.S. Patent. 2015 July 14;
    1. Couroux A.-M., Fadli A., Nicou V. Dyeing Composition Comprising a Heterocyclic Oxidation Base and a Cationic 3,5-Diaminopyridine Coupler. 2012080286. WO Patent. 2012 June 21;

LinkOut - more resources